SCM
ALXN
Sarissa Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-650,440
| Closed | -$119M | – | 15 |
|
|
2021
Q2 | $119M | Hold |
650,440
| – | – | 9.5% | 5 |
|
|
2021
Q1 | $99.5M | Sell |
650,440
-147,300
| -18% | -$22.5M | 9.53% | 5 |
|
|
2020
Q4 | $125M | Hold |
797,740
| – | – | 12.72% | 5 |
|
|
2020
Q3 | $91.3M | Buy |
797,740
+54,240
| +7% | +$6.21M | 10.75% | 5 |
|
|
2020
Q2 | $83.5M | Buy |
743,500
+608,500
| +451% | +$68.3M | 9.28% | 6 |
|
|
2020
Q1 | $12.1M | Buy |
+135,000
| New | +$12.1M | 1.55% | 9 |
|